| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |